Abstracts for the 24th Pupil Colloquium

The 24th Pupil Colloquium will be held in Assilomar, California, 7th - 11th September 2001

For information about accommodation, and registration, please check the following web page:


Presentations will be by paper, and it is intended to allow 20 minutes in total for each presentation (15 mins talk and 5 mins discussion). If you wish to submit an abstract for this conference, the deadline for RECEIPT of abstracts is 15 July 2001.

My preference is for email submissions, or word processed documents (Microsoft Word, or HTML).

These should be sent to the Programme Organiser: p.a.howarth@lboro.ac.uk

If you do have to post the abstract, please send it to:

Dr. Peter Howarth
Department of Human Sciences
Loughborough University
Leicestershire LE11 3TU


TITLE - The title of the presentation should be in ALL CAPITAL LETTERS.

AUTHOR(S) - The title should be followed by each author's name, highest professional degree, highest academic degree (omit punctuation), and any academic or company affiliations. The presenting author's name must be listed first. No more than five authors will be published for any given abstract.

ABSTRACT - Abstracts should be 500 words or less (about 30 lines of text), including title, author names and affiliations. Each abstract which is accepted will be included in the printed transactions and on the Colloquium web site. Abstracts which exceed the 500-word limit may be truncated. Authors are encouraged to keep the abstracts succinct, to avoid long author lists, and to list only one institutional affiliation per author to avoid exceeding the word limit.

ABSTRACT CONTENT - Where possible, the abstract should include the following information

a) INTRODUCTION : the purpose of the study.

b) METHODS : the experimental design, subjects, and procedures.

c) RESULTS : the major results obtained (the study must be completed prior to submission of the abstract).

d) DISCUSSION : your interpretation of the importance of the results.

FORMATTING - It is important that the message contain only printable, ASCII text (the list of valid characters includes ~!@#$%^& * ()_+{ }|:"<>? ` -=[ ]\ /; ', .). NO SPECIAL CONTROL CHARACTERS OR OTHER NON-PRINTABLE CHARACTERS ARE TO BE INCLUDED IN THE ABSTRACT FIELD!! Authors should use an English-language keyboard. The "" symbol should be avoided in favour of the three-character substitute "+/-". International authors should be aware that many diacritical marks (such as circumflex or umlaut) are treated by the computer as special control characters and therefore should be avoided unless essential to convey scientific content.

SPECIAL INSTRUCTIONS - If absolutely necessary, special instructions regarding formatting not covered in the following examples may be given to the Programme Organiser. For example, the author may wish to indicate the need for a Greek letter, a mathematical symbol, or other special formatting that is essential to the scientific content of the abstract. Special instructions are tedious to process, so judicious usage is appreciated.

If special formatting is essential for scientiUse of uninitialized value in concatenation (.) or string at E:\listplex\SYSTEM\SCRIPTS\filearea.cgi line 455, line 48. fic clarity, authors may imbed a limited amount of formatting information within the text of abstracts using special tags as detailed below. To display text in italics, bold, underscored, superscript, or subscript, authors should add the appropriate tags immediately before and after the characters to be formatted. The following tags conform to international standards of the Hyper Text Markup Language (HTML).

To get Italics specimens of <i>e. coli</i> were prepared

To get bold matrix <b>M</b> was calculated

To underscore colour was <u>not</u> a factor

To get superscript the formula y = x<sup>2</sup> was used

To get subscript distilled H<sub>2</sub>O was combined

CONFLICT OF INTEREST - If any author has a potential conflict of interest or has received financial benefit from this study, a statement to this effect must be included at the end of the abstract.

CERTIFICATION - Please certify, at the end of the abstract, that your abstract complies with the following ethical standards, as appropriate: 1) research that involves human subjects was conducted in accordance with the guidelines provided by the Declaration of Helsinki and in adherence to applicable national and local Human-Subjects requirements, 2) research that involves animal subjects was conducted in accordance with international standards of animal care and treatment, as published, for example, by the Society for Neuroscience and ARVO, and 3) all co-authors have read the final, submitted version of the abstract and consented explicitly to having their names included in the list of authors.

ACKNOWLEDGEMENT OF GRANT SUPPORT - Authors wishing to acknowledge funding agencies should do so at the end of the abstract.

COMMUNICATING AUTHOR - The Programme Organiser will correspond with the designated communicating author when necessary. Please provide the name, complete mailing address, phone number(s) and PREFERABLY the e-mail address (if available) of the author who is to receive any correspondence.

URL ADDRESS - Authors may elect to publish the URL address of the author's institutional WEB site which contains additional materials relating to the author's abstract. Such materials might include electronic copies of lecture slides or poster figures, additional data, models, simulations and whatever the author wishes to make available for public access over the WEB. Submitted URLs will be published as part of the author's abstract.